Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.040 | 21 | 33403138 | 5 prime UTR variant | T/C;G | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 21 | 33403138 | 5 prime UTR variant | T/C;G | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 21 | 33403138 | 5 prime UTR variant | T/C;G | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases | 0.800 | 1.000 | 4 | 2012 | 2017 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases; Infections | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.240 | 21 | 33404389 | intron variant | A/G | snv | 0.69 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.701 | 0.400 | 21 | 33415005 | missense variant | A/G | snv | 0.20 | 0.18 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |